Insights

Clinical Research Management Webinar Series: Regulatory Considerations for Biorepositories Navigating HHS FDA HIPAA and Informed Consent

By: Madeleine Williams and Scott Jewell

In this webinar, we briefly discussed the regulatory considerations for biorepositories including the following:

  • When HHS, FDA and HIPAA regulations apply
  • When informed consent is not required
  • Pros and cons of different informed consent approaches

Webinar:Regulatory Considerations for Biorepositories: Navigating HHS, FDA, HIPAA and Informed Consent

Slides: Regulatory Considerations for Biorepositories: Navigating HHS, FDA, HIPAA and Informed Consent

Related Information

SEARCH
ADVANCED SEARCH